The rate of bone loss slows after 1-2 years of initial antiretroviral therapy: final results of the START bone mineral density substudy

OBJECTIVE: Initial antiretroviral therapy (ART) causes loss of bone mineral density (BMD) over the first 1–2 years. Whether this loss continues with longer therapy is unclear. DESIGN AND METHODS: In the START BMD substudy, ART-naïve adults with CD4 counts >500 cells/μL were randomised to immediat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:HIV Med
Asıl Yazarlar: Carr, Andrew, Grund, Birgit, Schwartz, Ann V, Avihingsanon, Anchalee, Badal-Faesen, Sharlaa, Bernadino, Jose I, Estrada, Vicente, Rosa, Alberto La, Mallon, Patrick WG, Pujari, Sanjay, White, David, Engen, Nicole Wyman, Ensrud, Kristine, Hoy, Jennifer F
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2019
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8224176/
https://ncbi.nlm.nih.gov/pubmed/31642586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12796
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller